NF-κB is a stimulatory transcription factor that is ubiquitous in almost all kinds of cells. When cells are under various stimuli, NF-κB is activated and regulates large numbers of target genes, and thus controls important cellular processes, ranging from cell growth and differentiation to apoptosis and cancer. Therefore, NF-κB is a forefront hotspot transcription factor that is intensively studied in virtually all fields of biomedical sciences, and becomes a promising target for disease therapy and drug development. The activity detection is the first and inevitable step for the studies of NF-κB activation and function, therefore, the techniques for the detection of NF-κB activity have always been paid more attention and continuously developed. Especially in recent year, along with the development of each disciplines, multiple various new techniques have been developed, including ELISA-like assays based on dsDNA-coupled plate, filter binding assays, FRET assays, fluorescence reporting and nucleic acids amplification assays based on exonuclease and endonuclease, MS and flow cytometry assays based on immunomicrobeads, and other biophysical and electrochemical assays. Some of these techniques have already played important roles in NF-κB studies. This paper reviewed new techniques developed in recent years by classification, in order to provide researchers an overview of NF-κB activity assays, which may be helpful for their selection of appropriate techniques for their studies. Moreover, the learning and understanding of these techniques may inspire researchers to improve the current techniques and develop novel methods for the studies of NF-κB.
[1] Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 1986, 46(5): 705-716.
[2] Grilli M, Chiu JJS, Lenardo MJ. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol, 1993, 143: 1-62.
[3] Kopp EB, Ghosh S. NF-κB and Rel proteins in innate immunity. Adv Immunol, 1995, 58: 1-27.
[4] Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev, 1995, 9(22): 2723-2735.
[5] Huxford T, Huang DB, Malek S, Ghosh G. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell, 1998, 95(6): 759-770.
[6] Jacobs MD, Harrison SC. Structure of an IκBα/NF-κB complex. Cell, 1998, 95(6): 749 -758.
[7] Chen FE, Huang DB, Chen YQ, Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature, 1998, 391(6665): 410-413.
[8] Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene, 1999, 18(49): 6853-6866.
[9] Lim CA, Yao F, Wong JJY, George J, Xu H, Chiu KP, Sung WK, Lipovich L, Vega VB, Chen J, Shahab A, Zhao XD, Hibberd M, Wei CL, Lim B, Ng HH, Ruan YJ, Chin KC. Genome-wide mapping of RELA (p65) binding identifies E2F1 as a transcriptional activator recruited by NF-κB upon TLR4 activation. Mol Cell, 2007, 27(4): 622-635.
[10] Giorgetti L, Siggers T, Tiana G, Caprara G, Notarbartolo S, Corona T, Pasparakis M, Milani P, Bulyk ML, Natoli G. Noncooperative interactions between transcription factors and clustered DNA binding sites enable graded transcriptional responses to environmental inputs. Mol Cell, 2010, 37(3): 418-428.
[11] Bunting K, Rao S, Hardy K, Woltring D, Denyer GS, Wang J, Gerondakis S, Shannon MF. Genome- wide analysis of gene expression in T cells to identify targets of the NF-κB transcription factor c-Rel. J Immunol, 2007, 178(11): 7097-7109.
[12] Tian B, Nowak DE, Jamaluddin M, Wang SF, Brasier AR. Identification of direct genomic targets downstream of the nuclear factor-κB transcription factor mediating tumor necrosis factor signaling. J Biol Chem, 2005, 280(17): 17435-17448.
[13] Kasowski M, Grubert F, Heffelfinger C, Hariharan M, Asabere A, Waszak SM, Habegger L, Rozowsky J, Shi M, Urban AE, Hong MY, Karczewski KJ, Huber W, Weissman SM, Gerstein MB, Korbel JO, Snyder M. Variation in transcription factor binding among humans. Science, 2010, 328(5975): 232-235.
[14] Caamano J, Hunter CA. NF-κB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev, 2002, 15(3): 414-429.
[15] Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest, 2001, 107(1): 7-11.
[16] Rayet B, Gélinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 1999, 18(49): 6938-6947.
[17] Ghosh S, May MJ, Kopp EB. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol, 1998, 16(1): 225-260.
[18] Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, Yamamoto N. Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood, 1999, 93(7): 2360- 2368.
[19] Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B. Constitutive nuclear factor-κB- RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest, 1997, 100(12): 2961-2969.
[20] Wood LD, Richmond A. Constitutive and cytokine- induced expression of the melanoma growth stimulatory activity/GROα gene r
